Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review

被引：11

作者：

Lominadze, Zurabi ^{[1
]}

Hill, Kareen ^{[2
]}

Shaik, Mohammed Rifat ^{[3
]}

Canakis, Justin P. ^{[4
]}

Bourmaf, Mohammad ^{[2
]}

Adams-Mardi, Cyrus ^{[4
]}

Abutaleb, Ameer ^{[5
]}

Mishra, Lopa ^{[6
]}

Shetty, Kirti ^{[1
]}

机构：

[1] Univ Maryland, Dept Med, Div Gastroenterol & Hepatol, Sch Med, Baltimore, MD 21201 USA

[2] Univ Maryland, Dept Med, Med Ctr, Baltimore, MD 21201 USA

[3] Univ Maryland, Dept Med, Med Ctr, Midtown Campus, Baltimore, MD 21201 USA

[4] George Washington Univ, Dept Med, Sch Med & Hlth Sci, Washington, DC 20037 USA

[5] George Washington Univ, Dept Surg, Sch Med & Hlth Sci, Washington, DC 20037 USA

[6] Northwell Hlth, Feinstein Inst Med Res, Div Gastroenterol & Hepatol, Cold Spring Harbor Lab, Manhasset, NY 11030 USA

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 03期

关键词：

hepatocellular carcinoma; immunotherapy; liver transplantation; allograft rejection; REGULATORY T-CELLS; CANCER-PATIENTS; RECURRENCE; THERAPY; RISK; DURVALUMAB; NIVOLUMAB; ANTITUMOR; RESECTION; MELANOMA;

D O I：

10.3390/ijms24032358

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The emerging field of immuno-oncology has brought exciting developments in the treatment of hepatocellular carcinoma (HCC). It has also raised urgent questions about the role of immunotherapy in the setting of liver transplantation, both before and after transplant. A growing body of evidence points to the safety and efficacy of immunotherapeutic agents as potential adjuncts for successful down-staging of advanced HCCs to allow successful transplant in carefully selected patients. For patients with recurrent HCC post-transplant, immunotherapy has a limited, yet growing role. In this review, we describe optimal regimens in the setting of liver transplantation.

引用

页数：16

共 50 条

[41] Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study [J].

Kim, Jongman ;

Joo, Dong-Jin ;

Hwang, Shin ;

Lee, Jeong-Moo ;

Ryu, Je-Ho ;

Nah, Yang-Won ;

Kim, Dong-Sik ;

Kim, Doo-Jin ;

You, Young-Kyoung ;

Yu, Hee-Chul .

WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (07) :1340-1353

[42] Downstaging Hepatocellular Carcinoma before Transplantation Role of Immunotherapy Versus Locoregional Approaches [J].

Lindemann, Jessica ;

Yu, Jennifer ;

Doyle, Maria Bernadette Majella .

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (01) :143-158

[43] Perspectives on immunotherapy for hepatocellular carcinoma [J].

Schmidt, N. ;

Buettner, N. ;

Thimme, R. .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (14) :740-743

[44] Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver [J].

Marzi, Luca ;

Mega, Andrea ;

Turri, Chiara ;

Gitto, Stefano ;

Ferro, Federica ;

Spizzo, Gilbert .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)

[45] Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review [J].

Toniutto, Pierluigi ;

Fumolo, Elisa ;

Fornasiere, Ezio ;

Bitetto, Davide .

JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)

[46] Liver transplantation for hepatocellular carcinoma [J].

Sudeep Tanwar ;

Shahid A Khan ;

Vijay Paul Bob Grover ;

Catherine Gwilt ;

Belinda Smith ;

Ashley Brown .

World Journal of Gastroenterology, 2009, 15 (44) :5511-5516

[47] Liver transplantation for hepatocellular carcinoma [J].

Dourakis, S. P. .

ARCHIVES OF HELLENIC MEDICINE, 2009, 26 (01) :7-22

[48] Liver transplantation for hepatocellular carcinoma [J].

Durand, F ;

Belghiti, J .

HEPATO-GASTROENTEROLOGY, 2002, 49 (43) :47-52

[49] Liver transplantation and hepatocellular carcinoma [J].

Yokoyama, I ;

Takagi, H .

SEMINARS IN SURGICAL ONCOLOGY, 1996, 12 (03) :212-216

[50] Liver Transplantation for Hepatocellular Carcinoma [J].

Chan, See Ching .

LIVER CANCER, 2013, 2 (3-4) :338-344

← 1 2 3 4 5 →